在慢性淋巴细胞白血病中优化易布鲁替尼的剂量,使用半机械药量计框架
Eman I K Ibrahim1, Lena E Friberg1
1Department of Pharmacy, Uppsala University, Uppsala, Sweden.
CPT: pharmacometrics & systems pharmacology
|October 11, 2025
概括
在慢性淋巴细胞白血病 (CLL) 中优化易布鲁替尼的剂量可以降低毒性. 较低剂量,有或没有venetoclax,保持疗效和无进展的存活率,支持个性化的CLL治疗.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 血液学 瘤学 癌症学
- 翻译医学是一种翻译医学.
背景情况:
- 易布鲁替尼是慢性淋巴细胞白血病 (CLL) 的一个关键的布鲁顿氨酸激酶 (Btk) 抑制剂.
- 诸如高血压之类的不良事件往往需要剂量修改,影响治疗的坚持和结果.
- 低剂量易布鲁替尼,特别是与venetoclax结合使用,需要进一步研究疗效和安全性.
研究的目的:
- 探索ibrutinib单独或与venetoclax一起用于未经治疗的 (TN) 和复发/耐药 (R/R) CLL的剂量优化策略.
- 使用基于模型的方法来描述ibrutinib暴露与疗效/安全生物标志物之间的关系.
- 模拟替代剂量方案,以提高耐受性和个性化的CLL管理.
主要方法:
- 利用了1b/2和3期研究的数据,包括血度和临床生物标志物.
- 重新评估并扩展了一种半机械的人口药理动力学-药理动力学 (PKPD) 框架.
- 集成的额外生物标志物和模拟的替代剂量策略用于TN和R/RCLL患者.
主要成果:
- 该PKPD模型准确地捕获了生物标志物动态,揭示了TN和R/R患者之间的基Btk和CLL细胞半衰期的差异.
- 剂量减少维持了与标准剂量相比较的响应率和无进展生存率.
- 用venetoclax降低易布鲁替尼的升级,在2年内对可测量的残留疾病产生了最小的影响.
结论:
- 开发的PKPD框架支持个性化ibrutinib剂量,以提高耐受性而不会影响CLL的疗效.
- 剂量优化策略可以改善患者的治疗结果和CLL管理的坚持.
- 这种方法为慢性淋巴细胞白血病提供了更加个性化和有效的治疗途径.
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.3K
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
15.3K
相关概念视频
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
150
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
150
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
218
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
218
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
208
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
208
01:28Dosage Regimens: Designs and Approaches
261
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
261
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
232
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
232
01:23Dosage Regimen Designs: Nomograms and Tabulations
179
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
179